230 related articles for article (PubMed ID: 33545564)
21. Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System.
Velugula-Yellela SR; Powers DN; Angart P; Faustino A; Faison T; Kohnhorst C; Fratz-Berilla EJ; Agarabi CD
J Vis Exp; 2019 May; (147):. PubMed ID: 31107445
[TBL] [Abstract][Full Text] [Related]
22. Inter-laboratory study of an optimised peptide mapping workflow using automated trypsin digestion for monitoring monoclonal antibody product quality attributes.
Millán-Martín S; Jakes C; Carillo S; Buchanan T; Guender M; Kristensen DB; Sloth TM; Ørgaard M; Cook K; Bones J
Anal Bioanal Chem; 2020 Oct; 412(25):6833-6848. PubMed ID: 32710279
[TBL] [Abstract][Full Text] [Related]
23. Targeted CQA analytical control strategy for commercial antibody products: Replacing ion-exchange chromatography methods for charge heterogeneity with multi-attribute monitoring.
Evans AR; Mulholland J; Lewis MJ; Hu P
MAbs; 2024; 16(1):2341641. PubMed ID: 38652517
[TBL] [Abstract][Full Text] [Related]
24. Multi-attribute method performance profile for quality control of monoclonal antibody therapeutics.
Hao Z; Moore B; Ren C; Sadek M; Macchi F; Yang L; Harris J; Yee L; Liu E; Tran V; Ninonuevo M; Chen Y; Yu C
J Pharm Biomed Anal; 2021 Oct; 205():114330. PubMed ID: 34479173
[TBL] [Abstract][Full Text] [Related]
25. A View on the Importance of "Multi-Attribute Method" for Measuring Purity of Biopharmaceuticals and Improving Overall Control Strategy.
Rogers RS; Abernathy M; Richardson DD; Rouse JC; Sperry JB; Swann P; Wypych J; Yu C; Zang L; Deshpande R
AAPS J; 2017 Nov; 20(1):7. PubMed ID: 29192343
[TBL] [Abstract][Full Text] [Related]
26. A native multi-dimensional monitoring workflow for at-line characterization of mAb titer, size, charge, and glycoform heterogeneities in cell culture supernatant.
Bhattacharya S; Joshi S; Rathore AS
J Chromatogr A; 2023 May; 1696():463983. PubMed ID: 37054641
[TBL] [Abstract][Full Text] [Related]
27. Improvements on sample preparation and peptide separation for reduced peptide mapping based multi-attribute method analysis of therapeutic monoclonal antibodies using lysyl endopeptidase digestion.
Li X; Rawal B; Rivera S; Letarte S; Richardson DD
J Chromatogr A; 2022 Jul; 1675():463161. PubMed ID: 35635865
[TBL] [Abstract][Full Text] [Related]
28. Development and optimization of a LC-MS based multi-attribute method (MAM) workflow for characterization of therapeutic Fc-fusion protein.
Puranik A; Rasam P; Dandekar P; Jain R
Anal Biochem; 2023 Jan; 660():114969. PubMed ID: 36343663
[TBL] [Abstract][Full Text] [Related]
29. Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry.
Qu M; An B; Shen S; Zhang M; Shen X; Duan X; Balthasar JP; Qu J
Mass Spectrom Rev; 2017 Nov; 36(6):734-754. PubMed ID: 27097288
[TBL] [Abstract][Full Text] [Related]
30. Multidimensional LC-MS with
Verscheure L; Detremmerie S; Stals H; De Vos J; Sandra P; Lynen F; Borgions F; Sandra K
J Chromatogr A; 2024 Jul; 1726():464947. PubMed ID: 38724406
[TBL] [Abstract][Full Text] [Related]
31. Implementation of a LC-MS based multi-attribute method (MAM) and intact multi-attribute method (iMAM) workflow for the characterisation of a GLP-Fc fusion protein.
Buckley C; Millán-Martín S; Carillo S; Füssl F; MacHale C; Bones J
Anal Biochem; 2024 Jun; 693():115585. PubMed ID: 38851475
[TBL] [Abstract][Full Text] [Related]
32. A Quadrupole Dalton-based multi-attribute method for product characterization, process development, and quality control of therapeutic proteins.
Xu W; Jimenez RB; Mowery R; Luo H; Cao M; Agarwal N; Ramos I; Wang X; Wang J
MAbs; 2017 Oct; 9(7):1186-1196. PubMed ID: 28805536
[TBL] [Abstract][Full Text] [Related]
33. Chip-Based Capillary Zone Electrophoresis Mass Spectrometry for Rapid Resolution and Quantitation of Critical Quality Attributes in Protein Biotherapeutics.
Dykstra AB; Flick TG; Lee B; Blue LE; Angell N
J Am Soc Mass Spectrom; 2021 Aug; 32(8):1952-1963. PubMed ID: 33730487
[TBL] [Abstract][Full Text] [Related]
34. Toward unbiased identification and comparative quantification of host cell protein impurities by automated iterative LC-MS/MS (HCP-AIMS) for therapeutic protein development.
Huang Y; Molden R; Hu M; Qiu H; Li N
J Pharm Biomed Anal; 2021 Jun; 200():114069. PubMed ID: 33901758
[TBL] [Abstract][Full Text] [Related]
35. An evaluation of instrument types for mass spectrometry-based multi-attribute analysis of biotherapeutics.
Zhang Z; Chan PK; Richardson J; Shah B
MAbs; 2020; 12(1):1783062. PubMed ID: 32643531
[TBL] [Abstract][Full Text] [Related]
36. Advancing Mass Spectrometry Technology in cGMP Environments.
Ren D
Trends Biotechnol; 2020 Oct; 38(10):1051-1053. PubMed ID: 32718778
[TBL] [Abstract][Full Text] [Related]
37. Routine Analysis of N-Glycans Using Liquid Chromatography Coupled to Routine Mass Detection.
Zhang X; Vimalraj V; Patel M
Methods Mol Biol; 2021; 2271():205-219. PubMed ID: 33908010
[TBL] [Abstract][Full Text] [Related]
38. A comprehensive strategy for the identification of biologics by liquid-chromatography-mass spectrometry for release testing in a regulated environment.
Morales A; Candreva J; Jayarathne T; Esterman AL; Voruganti S; Flagg SC; Slaney T; Liu P; Adamo M; Patel S; Das TK; Zeng M; Li X
J Pharm Biomed Anal; 2023 Sep; 234():115580. PubMed ID: 37478550
[TBL] [Abstract][Full Text] [Related]
39. Multi-Attribute Method (MAM): An Emerging Analytical Workflow for Biopharmaceutical Characterization, Batch Release and cGMP Purity Testing at the Peptide and Intact Protein Level.
Millán-Martín S; Jakes C; Carillo S; Gallagher L; Scheffler K; Broster K; Bones J
Crit Rev Anal Chem; 2023 Jul; ():1-18. PubMed ID: 37490277
[TBL] [Abstract][Full Text] [Related]
40. Development of a 3D-LC/MS Workflow for Fast, Automated, and Effective Characterization of Glycosylation Patterns of Biotherapeutic Products.
Camperi J; Dai L; Guillarme D; Stella C
Anal Chem; 2020 Mar; 92(6):4357-4363. PubMed ID: 32079391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
